JHOP - August 2023 Vol 13, No 4

Effects of Vascular Endothelial Growth Factor Inhibitor–Induced Proteinuria on Treatment Course and Outcomes: Retrospective Analysis and Review of the Literature

Joshua L. Murdock, PharmD; Marissa R. Duco, PharmD; David J. Reeves, PharmD, BCOP

Effects of Levofloxacin Prophylaxis in Pediatric Patients With Acute Myeloid Leukemia, Relapsed Acute Lymphoblastic Leukemia, or Patients Undergoing Hematopoietic Stem Cell Transplant

Livia Linden, PharmD, BCPPS; Sarah Timaeus, PharmD, BCOP; Jessica Gillon, PharmD, BCIDP; Savannah Gulley, PharmD, BCPPS

Duration of Response to PARP Inhibitors for Maintenance Treatment of Ovarian Cancer in Patients With Germline or Somatic HRD

Jordanne Adolphsen, PharmD, BCOP; Taylor Monson, PharmD, BCOP; Grace Martin, PharmD, BCOP; Zahra Mahmoudjafari, PharmD, BCOP; Richard Meier, PhD; Whitney Shae, BS, MS; Devin C. Koestler, PhD; Colleen Bohnenkamp, PharmD, BCOP

Practical Issues in Pharmacy Management

Impact of Pharmacist-Led Oral Chemotherapy Telehealth Clinic at a Community Cancer Center Using the TAMER Model

Diana Tamer, PharmD, BCOP; Timothy Schieber, PharmD, MBA; Jake Wodtke, PharmD; Samira Zantout, PharmD, BCPS

Review Article

A Review of Clinical Data Among Biosimilars: Just How Similar Are They?

Dennis Marjoncu, PharmD, BCOP

FDA Oncology Update

FDA Accelerated the Approval of Columvi for Selected Relapsed or Refractory Large B-Cell Lymphomas

Lonsurf Received a New Indication, in Combination With Bevacizumab, for Previously Treated Metastatic Colorectal Cancer

Jemperli Plus Chemotherapy Now FDA Approved for Front-Line Treatment of dMMR or MSI-H Endometrial Cancer

Vanflyta Now Approved for Newly Diagnosed FLT3-ITD–Positive AML

Talzenna Received a New Indication, With Enzalutamide, for Metastatic Castration-Resistant Prostate Cancer With HRR Gene Mutation

Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive:

JHOP Print Edition

JHOP Weekly e‑Newsletter

I have reviewed and consent to the terms of JHOP's Privacy Policy, and JHOP has my permission to retain my information in its database, and to forward pertinent communications to me.